- Home
- Publications
- Publication Search
- Publication Details
Title
Immune checkpoint therapy in liver cancer
Authors
Keywords
Immune checkpoint, Hepatocellular carcinoma, Cholangiocarcinoma, Immunotherapy, Epigenetics
Journal
JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
Volume 37, Issue 1, Pages -
Publisher
Springer Nature
Online
2018-05-29
DOI
10.1186/s13046-018-0777-4
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Targeting Epigenetics in Cancer
- (2018) Richard L. Bennett et al. Annual Review of Pharmacology and Toxicology
- Combination Cancer Therapy with Immune Checkpoint Blockade: Mechanisms and Strategies
- (2018) Shetal A. Patel et al. IMMUNITY
- The signature of liver cancer in immune cells DNA methylation
- (2018) Yonghong Zhang et al. Clinical Epigenetics
- Clinical Grade Regulatory CD4+ T Cells (Tregs): Moving Toward Cellular-Based Immunomodulatory Therapies
- (2018) Richard Duggleby et al. Frontiers in Immunology
- Progressive epigenetic dysregulation in neuroendocrine tumour liver metastases
- (2017) Anna Karpathakis et al. ENDOCRINE-RELATED CANCER
- Antibodies Against Immune Checkpoint Molecules Restore Functions of Tumor-Infiltrating T Cells in Hepatocellular Carcinomas
- (2017) Guoying Zhou et al. GASTROENTEROLOGY
- Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy
- (2017) Leslie S. Kean et al. IMMUNOLOGICAL REVIEWS
- Epigenetic regulation of immune checkpoints: another target for cancer immunotherapy?
- (2017) Mahmoud A Ali et al. Immunotherapy
- Safety and Antitumor Activity of Pembrolizumab in Advanced Programmed Death Ligand 1–Positive Endometrial Cancer: Results From the KEYNOTE-028 Study
- (2017) Patrick A. Ott et al. JOURNAL OF CLINICAL ONCOLOGY
- STAT3-blocked whole-cell hepatoma vaccine induces cellular and humoral immune response against HCC
- (2017) Qiuju Han et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Current progress in immunotherapy of hepatocellular carcinoma
- (2017) Martin F. Sprinzl et al. JOURNAL OF HEPATOLOGY
- Nivolumab in patients with advanced hepatocellular carcinoma (CheckMate 040): an open-label, non-comparative, phase 1/2 dose escalation and expansion trial
- (2017) Anthony B El-Khoueiry et al. LANCET
- Epigenetics and immunotherapy: The current state of play
- (2017) Jennifer Dunn et al. MOLECULAR IMMUNOLOGY
- Targeting the PD-L1/DNMT1 axis in acquired resistance to sorafenib in human hepatocellular carcinoma
- (2017) Jianhua Liu et al. ONCOLOGY REPORTS
- The PD-1/PD-L1 axis may be aberrantly activated in occupational cholangiocarcinoma
- (2017) Yasunori Sato et al. PATHOLOGY INTERNATIONAL
- Tumor-derived CD4+CD25+regulatory T cells inhibit dendritic cells function by CTLA-4
- (2017) Xin Chen et al. PATHOLOGY RESEARCH AND PRACTICE
- Epigenetic therapy activates type I interferon signaling in murine ovarian cancer to reduce immunosuppression and tumor burden
- (2017) Meredith L. Stone et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Structural basis for cancer immunotherapy by the first-in-class checkpoint inhibitor ipilimumab
- (2017) Udupi A. Ramagopal et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Positive Expression of Programmed Death Ligand 1 in Peritumoral Liver Tissue is Associated with Poor Survival after Curative Resection of Hepatocellular Carcinoma
- (2017) Xiaomeng Dai et al. Translational Oncology
- A competing endogenous RNA network identifies novel mRNA, miRNA and lncRNA markers for the prognosis of diabetic pancreatic cancer
- (2017) Kanyu Yao et al. TUMOR BIOLOGY
- The Histone Methyltransferase Ezh2 Controls Mechanisms of Adaptive Resistance to Tumor Immunotherapy
- (2017) Daniel Zingg et al. Cell Reports
- Epigenetic modifications of the immune-checkpoint genes CTLA4 and PDCD1 in non-small cell lung cancer results in increased expression
- (2017) Sebastian Marwitz et al. Clinical Epigenetics
- Epidemiology and risk factors: intrahepatic cholangiocarcinoma
- (2017) Amar Gupta et al. HEPATOBILIARY SURGERY AND NUTRITION
- CTLA-4 and PD-1 Pathways
- (2016) Elizabeth I. Buchbinder et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Program Death 1 Immune Checkpoint and Tumor Microenvironment: Implications for Patients With Intrahepatic Cholangiocarcinoma
- (2016) Faiz Gani et al. ANNALS OF SURGICAL ONCOLOGY
- Facilitating T Cell Infiltration in Tumor Microenvironment Overcomes Resistance to PD-L1 Blockade
- (2016) Haidong Tang et al. CANCER CELL
- Combining Epigenetic and Immunotherapy to Combat Cancer
- (2016) Katherine B. Chiappinelli et al. CANCER RESEARCH
- Programmed death ligand 1 expression in hepatocellular carcinoma: Relationship With clinical and pathological features
- (2016) Julien Calderaro et al. HEPATOLOGY
- Lag-3, Tim-3, and TIGIT: Co-inhibitory Receptors with Specialized Functions in Immune Regulation
- (2016) Ana C. Anderson et al. IMMUNITY
- CXCL10/CXCR3 signaling mobilized-regulatory T cells promote liver tumor recurrence after transplantation
- (2016) Chang Xian Li et al. JOURNAL OF HEPATOLOGY
- Immune checkpoint proteins PD-1 and TIM-3 are both highly expressed in liver tissues and correlate with their gene polymorphisms in patients with HBV-related hepatocellular carcinoma
- (2016) Zhu Li et al. MEDICINE
- Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
- (2016) Supriya K. Saha et al. ONCOLOGIST
- CXCL12 expression and PD-L1 expression serve as prognostic biomarkers in HCC and are induced by hypoxia
- (2016) Alexander Semaan et al. VIRCHOWS ARCHIV
- Epigenetic epidemiology as a tool to understand the role of immunity in chronic disease
- (2016) Heather H Nelson et al. Epigenomics
- Adaptive resistance to therapeutic PD-1 blockade is associated with upregulation of alternative immune checkpoints
- (2016) Shohei Koyama et al. Nature Communications
- Immune Checkpoint Blockade in Hepatocellular Carcinoma: 2017 Update
- (2016) Masatoshi Kudo Liver Cancer
- Immune Checkpoint Blockade: A Common Denominator Approach to Cancer Therapy
- (2015) Suzanne L. Topalian et al. CANCER CELL
- Molecular Pathways: At the Crossroads of Cancer Epigenetics and Immunotherapy
- (2015) M. Maio et al. CLINICAL CANCER RESEARCH
- PD-L1 and HLA Class I Antigen Expression and Clinical Course of the Disease in Intrahepatic Cholangiocarcinoma
- (2015) F. Sabbatino et al. CLINICAL CANCER RESEARCH
- Tim-3 fosters HCC development by enhancing TGF-β-mediated alternative activation of macrophages
- (2015) Wenjiang Yan et al. GUT
- Epigenetic silencing of TH1-type chemokines shapes tumour immunity and immunotherapy
- (2015) Dongjun Peng et al. NATURE
- MiR-138 exerts anti-glioma efficacy by targeting immune checkpoints
- (2015) Jun Wei et al. NEURO-ONCOLOGY
- Loss of PTEN Promotes Resistance to T Cell-Mediated Immunotherapy
- (2015) W. Peng et al. Cancer Discovery
- Progression of Lung Cancer Is Associated with Increased Dysfunction of T Cells Defined by Coexpression of Multiple Inhibitory Receptors
- (2015) D. S. Thommen et al. Cancer Immunology Research
- HDAC Inhibition Upregulates PD-1 Ligands in Melanoma and Augments Immunotherapy with PD-1 Blockade
- (2015) D. M. Woods et al. Cancer Immunology Research
- Impaired Function of CD4+ T Follicular Helper (Tfh) Cells Associated with Hepatocellular Carcinoma Progression
- (2015) Yiqiong Jia et al. PLoS One
- Alterations of immune response of non-small cell lung cancer with Azacytidine
- (2015) John Wrangle et al. Oncotarget
- Therapeutic uses of anti-PD-1 and anti-PD-L1 antibodies
- (2014) G. K. Philips et al. INTERNATIONAL IMMUNOLOGY
- Epigenetic drugs as immunomodulators for combination therapies in solid tumors
- (2014) Luca Sigalotti et al. PHARMACOLOGY & THERAPEUTICS
- Metastasis is regulated via microRNA-200/ZEB1 axis control of tumour cell PD-L1 expression and intratumoral immunosuppression
- (2014) Limo Chen et al. Nature Communications
- Integrating novel therapeutic monoclonal antibodies into the management of head and neck cancer
- (2013) Julie E. Bauman et al. CANCER
- Locoregional therapy for cholangiocarcinoma
- (2013) Jan B. Kuhlmann et al. CURRENT OPINION IN GASTROENTEROLOGY
- Dendritic Cell-Based Immunotherapy Targeting Synthesized Peptides for Advanced Biliary Tract Cancer
- (2013) Masanori Kobayashi et al. JOURNAL OF GASTROINTESTINAL SURGERY
- Expression of PD-L1, PD-L2, PD-1 and CTLA4 in myelodysplastic syndromes is enhanced by treatment with hypomethylating agents
- (2013) H Yang et al. LEUKEMIA
- SAHA/Vorinostat induces the expression of the CD137 receptor/ligand system and enhances apoptosis mediated by soluble CD137 receptor in a human breast cancer cell line
- (2012) DANIELA BELLAROSA et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- T-cell suppression mediated by regulatory T cells infiltrating hepatic tumors can be overcome by GITRL treatment
- (2012) Alexander Pedroza-Gonzalez et al. OncoImmunology
- Comparative analysis of various tumor-associated antigen-specific t-cell responses in patients with hepatocellular carcinoma
- (2011) Eishiro Mizukoshi et al. HEPATOLOGY
- Management of hepatocellular carcinoma: An update
- (2011) Jordi Bruix et al. HEPATOLOGY
- Platinum-based drugs disrupt STAT6-mediated suppression of immune responses against cancer in humans and mice
- (2011) W. Joost Lesterhuis et al. JOURNAL OF CLINICAL INVESTIGATION
- Pre-treatment with chemotherapy can enhance the antigenicity and immunogenicity of tumours by promoting adaptive immune responses
- (2009) W M Liu et al. BRITISH JOURNAL OF CANCER
- Kupffer Cell Suppression of CD8+ T Cells in Human Hepatocellular Carcinoma Is Mediated by B7-H1/Programmed Death-1 Interactions
- (2009) K. Wu et al. CANCER RESEARCH
- Interaction of B7-H1 on intrahepatic cholangiocarcinoma cells with PD-1 on tumor-infiltrating T cells as a mechanism of immune evasion
- (2009) Yufu Ye et al. JOURNAL OF SURGICAL ONCOLOGY
- Interaction of human PD-L1 and B7-1
- (2008) Manish J. Butte et al. MOLECULAR IMMUNOLOGY
- Epigenetics in Cancer
- (2008) Manel Esteller NEW ENGLAND JOURNAL OF MEDICINE
- CTLA-4 Control over Foxp3+ Regulatory T Cell Function
- (2008) K. Wing et al. SCIENCE
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search